title: How Reliable are Trial-based Prognostic Models in Real-world Patients with Metastatic Castration-resistant Prostate Cancer?
authors.affiliation: Turku Centre for Biotechnology, Turku, Finland; Department of Mathematics and Statistics, University of Turku, Turku, Finland.
authors.forename: Fatemeh
authors.initials: F
authors.lastname: Seyednasrollah
authors.affiliation: Turku Centre for Biotechnology, Turku, Finland; Department of Information Technology, University of Turku, Turku, Finland.
authors.forename: Mehrad
authors.initials: M
authors.lastname: Mahmoudian
authors.affiliation: Department of Oncology and Radiotherapy, Turku University Central Hospital, Turku, Finland.
authors.forename: Liisa
authors.initials: L
authors.lastname: Rautakorpi
authors.affiliation: Department of Oncology and Radiotherapy, Turku University Central Hospital, Turku, Finland; Department of Clinical Oncology, University of Turku, Turku, Finland.
authors.forename: Outi
authors.initials: O
authors.lastname: Hirvonen
authors.affiliation: Department of Pulmonary Diseases and Clinical Allergology, Turku University Hospital and University of Turku, Turku, Finland; Centre for Clinical Informatics, Turku University Hospital, Turku, Finland.
authors.forename: Tarja
authors.initials: T
authors.lastname: Laitinen
authors.affiliation: Department of Oncology and Radiotherapy, Turku University Central Hospital, Turku, Finland.
authors.forename: Sirkku
authors.initials: S
authors.lastname: Jyrkkiö
authors.affiliation: Turku Centre for Biotechnology, Turku, Finland. Electronic address: laura.elo@utu.fi.
authors.forename: Laura L
authors.initials: LL
authors.lastname: Elo
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001499:Bayes Theorem; D000066491:Clinical Decision-Making; D003661:Decision Support Techniques; D000077143:Docetaxel; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D018579:Patient Selection; D025341:Principal Component Analysis; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D016032:Randomized Controlled Trials as Topic / Q000379:methods*; D012107:Research Design; D012307:Risk Factors; D043823:Taxoids / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D043823:Taxoids; D000077143:Docetaxel